TNF and neoplasm: Although DMXAA alone did not show a striking anti-tumor activity in patients, pre-clinical results showed that a co-administration of DMXAA with other drugs has an increase in anti-tumor activity, through activation of immune system by tumor necrosis factor alpha (TNF-α) induction [31].